{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,18]],"date-time":"2026-11-18T18:35:12Z","timestamp":1795026912142,"version":"4.10.2"},"reference-count":65,"publisher":"American Association for Cancer Research (AACR)","issue":"8","funder":[{"name":"FONDECYT","award":["1140697"],"award-info":[{"award-number":["1140697"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad and FEDER funds","award":["PI13\/01258"],"award-info":[{"award-number":["PI13\/01258"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad and FEDER funds","award":["PI17\/01621"],"award-info":[{"award-number":["PI17\/01621"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad and FEDER funds","award":["PI16\/01580"],"award-info":[{"award-number":["PI16\/01580"]}]},{"name":"Ministerio de Econom\u00eda y Competitividad and FEDER funds","award":["DTS18\/00181"],"award-info":[{"award-number":["DTS18\/00181"]}]},{"DOI":"10.13039\/501100002704","name":"Asociaci\u00f3n Espa\u00f1ola contra el Cancer","doi-asserted-by":"publisher","award":["INVES192GARG"],"award-info":[{"award-number":["INVES192GARG"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002704","name":"Asociaci\u00f3n Espa\u00f1ola contra el Cancer","doi-asserted-by":"publisher","award":["GCTRA16015SEDA"],"award-info":[{"award-number":["GCTRA16015SEDA"]}],"id":[{"id":"10.13039\/501100002704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Ministerio de Ciencia Innovaci\u00f3n y Universidades and FEDER funds","award":["RTI2018-093596"],"award-info":[{"award-number":["RTI2018-093596"]}]}],"content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2021,4,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title\/>\n                    <jats:p>The extraordinary plasticity of glioma cells allows them to contribute to different cellular compartments in tumor vessels, reinforcing the vascular architecture. It was recently revealed that targeting glioma-derived pericytes, which represent a big percentage of the mural cell population in aggressive tumors, increases the permeability of the vessels and improves the efficiency of chemotherapy. However, the molecular determinants of this transdifferentiation process have not been elucidated. Here we show that mutations in EGFR stimulate the capacity of glioma cells to function as pericytes in a BMX- (bone marrow and X-linked) and SOX9-dependent manner. Subsequent activation of platelet-derived growth factor receptor beta in the vessel walls of EGFR-mutant gliomas stabilized the vasculature and facilitated the recruitment of immune cells. These changes in the tumor microenvironment conferred a growth advantage to the tumors but also rendered them sensitive to pericyte-targeting molecules such as ibrutinib or sunitinib. In the absence of EGFR mutations, high-grade gliomas were enriched in blood vessels, but showed a highly disrupted blood\u2013brain barrier due to the decreased BMX\/SOX9 activation and pericyte coverage, which led to poor oxygenation, necrosis, and hypoxia. Overall, these findings identify EGFR mutations as key regulators of the glioma-to-pericyte transdifferentiation, highlighting the intricate relationship between the tumor cells and their vascular and immune milieu. Our results lay the foundations for a vascular-dependent stratification of gliomas and suggest different therapeutic vulnerabilities determined by the genetic status of EGFR.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Significance:<\/jats:title>\n                    <jats:p>This study identifies the EGFR-related mechanisms that govern the capacity of glioma cells to transdifferentiate into pericytes, regulating the vascular and immune phenotypes of the tumors.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1158\/0008-5472.can-20-3558","type":"journal-article","created":{"date-parts":[[2021,2,16]],"date-time":"2021-02-16T04:26:48Z","timestamp":1613449608000},"page":"2142-2156","update-policy":"https:\/\/doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["Tumor-Derived Pericytes Driven by EGFR Mutations Govern the Vascular and Immune Microenvironment of Gliomas"],"prefix":"10.1158","volume":"81","author":[{"given":"Berta","family":"Segura-Collar","sequence":"first","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Garranzo-Asensio","sequence":"additional","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7847-7058","authenticated-orcid":false,"given":"Beatriz","family":"Herranz","sequence":"additional","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."},{"name":"2Facultad de Medicina, Universidad Francisco de Vitoria, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4135-860X","authenticated-orcid":false,"given":"Esther","family":"Hern\u00e1ndez-SanMiguel","sequence":"additional","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4304-2150","authenticated-orcid":false,"given":"Teresa","family":"Cejalvo","sequence":"additional","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e1rbara S.","family":"Casas","sequence":"additional","affiliation":[{"name":"3Laboratory of Stem Cells and Developmental Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ander","family":"Matheu","sequence":"additional","affiliation":[{"name":"4Cellular Oncology Group, Biodonostia Health Research Institute, San Sebastian, Spain."},{"name":"5IKERBASQUE, Basque Foundation for Science, Bilbao, Spain."},{"name":"6CIBERFES, Instituto de Salud Carlos III, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"P\u00e9rez-N\u00fa\u00f1ez","sequence":"additional","affiliation":[{"name":"7Dto. Neurocirug\u00eda, Hospital 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3548-9961","authenticated-orcid":false,"given":"Juan Manuel","family":"Sep\u00falveda-S\u00e1nchez","sequence":"additional","affiliation":[{"name":"8Instituto de Investigaciones Biom\u00e9dicas I+12, Hospital 12 de Octubre, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurelio","family":"Hern\u00e1ndez-La\u00edn","sequence":"additional","affiliation":[{"name":"8Instituto de Investigaciones Biom\u00e9dicas I+12, Hospital 12 de Octubre, Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ver\u00f3nica","family":"Palma","sequence":"additional","affiliation":[{"name":"3Laboratory of Stem Cells and Developmental Biology, Faculty of Sciences, Universidad de Chile, Santiago, Chile."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Gargini","sequence":"additional","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0709-4973","authenticated-orcid":false,"given":"Pilar","family":"S\u00e1nchez-G\u00f3mez","sequence":"additional","affiliation":[{"name":"1Neurooncology Unit, Unidad Funcional de Investigaci\u00f3n en Enfermedades Cr\u00f3nicas (UFIEC), Instituto de Salud Carlos III (ISCIII), Madrid, Spain."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1086","published-online":{"date-parts":[[2021,2,16]]},"reference":[{"key":"2022061706384886400_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 World Health Organization classification of tumors of the central nervous system: a summary","volume":"131","author":"Louis","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2022061706384886400_bib2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.ajpath.2012.06.030","article-title":"Mechanisms of glioma-associated neovascularization","volume":"181","author":"Hardee","year":"2012","journal-title":"Am J Pathol"},{"key":"2022061706384886400_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.cell.2013.02.021","article-title":"Glioblastoma stem cells generate vascular pericytes to support vessel function and tumor growth","volume":"153","author":"Cheng","year":"2013","journal-title":"Cell"},{"key":"2022061706384886400_bib4","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s10456-018-9621-x","article-title":"Targeting glioblastoma-derived pericytes improves chemotherapeutic outcome","volume":"21","author":"Guerra","year":"2018","journal-title":"Angiogenesis"},{"key":"2022061706384886400_bib5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/stem.1767","article-title":"Notch1 stimulation induces a vascularization switch with pericyte-like cell differentiation of glioblastoma stem cells","volume":"33","author":"Guichet","year":"2015","journal-title":"Stem Cells"},{"key":"2022061706384886400_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.ccell.2016.10.018","article-title":"Normalization of tumor vessels by Tie2 activation and Ang2 inhibition enhances drug delivery and produces a favorable tumor microenvironment","volume":"30","author":"Park","year":"2016","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib7","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s11060-016-2269-8","article-title":"Novel insights into vascularization patterns and angiogenic factors in glioblastoma subclasses","volume":"131","author":"Conroy","year":"2017","journal-title":"J Neurooncol"},{"key":"2022061706384886400_bib8","doi-asserted-by":"crossref","first-page":"eaax1501","DOI":"10.1126\/scitranslmed.aax1501","article-title":"The IDH-TAU-EGFR triad defines the neovascular landscape of diffuse gliomas","volume":"12","author":"Gargini","year":"2020","journal-title":"Sci Transl Med"},{"key":"2022061706384886400_bib9","doi-asserted-by":"crossref","first-page":"3465","DOI":"10.1007\/s00018-014-1608-1","article-title":"EGFR-dependent mechanisms in glioblastoma: towards a better therapeutic strategy","volume":"71","author":"Zahonero","year":"2014","journal-title":"Cell Mol Life Sci"},{"key":"2022061706384886400_bib10","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.3390\/ijms18061295","article-title":"EGFR and EGFRvIII promote angiogenesis and cell invasion in glioblastoma: combination therapies for an effective treatment","volume":"18","author":"Keller","year":"2017","journal-title":"Int J Mol Sci"},{"key":"2022061706384886400_bib11","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1038\/nprot.2007.104","article-title":"A combined ex\/in vivo assay to detect effects of exogenously added factors in neural stem cells","volume":"2","author":"Ferron","year":"2007","journal-title":"Nat Protoc"},{"key":"2022061706384886400_bib12","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1158\/1535-7163.MCT-14-0736","article-title":"Preclinical test of dacomitinib, an irreversible EGFR inhibitor, confirms its effectiveness for glioblastoma","volume":"14","author":"Zahonero","year":"2015","journal-title":"Mol Cancer Ther"},{"key":"2022061706384886400_bib13","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/s41398-018-0095-9","article-title":"hiPSC-derived neural stem cells from patients with schizophrenia induce an impaired angiogenesis","volume":"8","author":"Casas","year":"2018","journal-title":"Transl Psychiatry"},{"key":"2022061706384886400_bib14","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.3390\/cancers12113230","article-title":"Immune profiling of gliomas reveals a connection with Tau function and the tumor vasculature","volume":"12","author":"Cejalvo","year":"2020","journal-title":"Cancers"},{"key":"2022061706384886400_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1093\/neuonc\/noy088","article-title":"IDH mutation status is associated with distinct vascular gene expression signatures in lower-grade gliomas","volume":"20","author":"Zhang","year":"2018","journal-title":"Neuro Oncol"},{"key":"2022061706384886400_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrclinonc.2014.126","article-title":"Vessel caliber\u2013a potential MRI biomarker of tumour response in clinical trials","volume":"11","author":"Emblem","year":"2014","journal-title":"Nat Rev Clin Oncol"},{"key":"2022061706384886400_bib17","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s10456-014-9432-7","article-title":"Functional analysis reveals angiogenic potential of human mesenchymal stem cells from Wharton's jelly in dermal regeneration","volume":"17","author":"Edwards","year":"2014","journal-title":"Angiogenesis"},{"key":"2022061706384886400_bib18","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.ccell.2014.10.006","article-title":"Antiangiogenesis strategies revisited: from starving tumors to alleviating hypoxia","volume":"26","author":"Jain","year":"2014","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib19","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.ccr.2009.12.020","article-title":"Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1","volume":"17","author":"Verhaak","year":"2010","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1073\/pnas.1314341111","article-title":"miR-218 opposes a critical RTK-HIF pathway in mesenchymal glioblastoma","volume":"111","author":"Mathew","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706384886400_bib21","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.ccr.2006.02.019","article-title":"Molecular subclasses of high-grade glioma predict prognosis, delineate a pattern of disease progression, and resemble stages in neurogenesis","volume":"9","author":"Phillips","year":"2006","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib22","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1200\/JCO.2010.33.8715","article-title":"Evidence for sequenced molecular evolution of IDH1 mutant glioblastoma from a distinct cell of origin","volume":"29","author":"Lai","year":"2011","journal-title":"J Clin Oncol"},{"key":"2022061706384886400_bib23","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/modpathol.3801006","article-title":"Endosialin (CD248) is a marker of tumor-associated pericytes in high-grade glioma","volume":"21","author":"Simonavicius","year":"2008","journal-title":"Mod Pathol"},{"key":"2022061706384886400_bib24","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.molcel.2015.09.002","article-title":"EGFR mutation promotes glioblastoma through epigenome and transcription factor network remodeling","volume":"60","author":"Liu","year":"2015","journal-title":"Mol Cell"},{"key":"2022061706384886400_bib25","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.ccell.2020.06.003","article-title":"Cell lineage-based stratification for glioblastoma","volume":"38","author":"Wang","year":"2020","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib26","doi-asserted-by":"crossref","first-page":"6754040","DOI":"10.1155\/2019\/6754040","article-title":"SOX9 stem-cell factor: clinical and functional relevance in cancer","volume":"2019","author":"Aguilar-Medina","year":"2019","journal-title":"J Oncol"},{"key":"2022061706384886400_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.stem.2017.10.002","article-title":"Targeting glioma stem cell-derived pericytes disrupts the blood-tumor barrier and improves chemotherapeutic efficacy","volume":"21","author":"Zhou","year":"2017","journal-title":"Cell Stem Cell"},{"key":"2022061706384886400_bib28","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1172\/JCI200318549","article-title":"Endothelial and nonendothelial sources of PDGF-B regulate pericyte recruitment and influence vascular pattern formation in tumors","volume":"112","author":"Abramsson","year":"2003","journal-title":"J Clin Invest"},{"key":"2022061706384886400_bib29","doi-asserted-by":"crossref","first-page":"4123605","DOI":"10.1155\/2019\/4123605","article-title":"Role and molecular mechanisms of pericytes in regulation of leukocyte diapedesis in inflamed tissues","volume":"2019","author":"Rudziak","year":"2019","journal-title":"Mediators Inflamm"},{"key":"2022061706384886400_bib30","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.devcel.2011.04.019","article-title":"PDGFR\u03b2 signaling regulates mural cell plasticity and inhibits fat development","volume":"20","author":"Olson","year":"2011","journal-title":"Dev Cell"},{"key":"2022061706384886400_bib31","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1093\/neuonc\/now113","article-title":"EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation","volume":"18","author":"Eskilsson","year":"2016","journal-title":"Neuro Oncol"},{"key":"2022061706384886400_bib32","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1476-4598-12-31","article-title":"Epidermal growth factor receptor variant type III markedly accelerates angiogenesis and tumor growth via inducing c-myc mediated angiopoietin-like 4 expression in malignant glioma","volume":"12","author":"Katanasaka","year":"2013","journal-title":"Mol Cancer"},{"key":"2022061706384886400_bib33","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ccell.2018.03.020","article-title":"A glial signature and Wnt7 signaling regulate glioma-vascular interactions and tumor microenvironment","volume":"33","author":"Griveau","year":"2018","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib34","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.3174\/ajnr.A4484","article-title":"T1-weighted dynamic contrast-enhanced MRI as a noninvasive biomarker of epidermal growth factor receptor vIII status","volume":"36","author":"Arevalo-Perez","year":"2015","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022061706384886400_bib35","doi-asserted-by":"crossref","first-page":"E49","DOI":"10.3174\/ajnr.A4774","article-title":"T1-weighted dynamic contrast-enhanced MRI is a noninvasive marker of epidermal growth factor receptor vIII status in cancer stem cell-derived experimental glioblastomas","volume":"37","author":"Politi","year":"2016","journal-title":"AJNR Am J Neuroradiol"},{"key":"2022061706384886400_bib36","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1093\/neuonc\/noy033","article-title":"In vivo evaluation of EGFRvIII mutation in primary glioblastoma patients via complex multiparametric MRI signature","volume":"20","author":"Akbari","year":"2018","journal-title":"Neuro Oncol"},{"key":"2022061706384886400_bib37","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1093\/neuonc\/noy066","article-title":"Intratumoral heterogeneity of oxygen metabolism and neovascularization uncovers 2 survival-relevant subgroups of IDH1 wild-type glioblastoma","volume":"20","author":"Stadlbauer","year":"2018","journal-title":"Neuro Oncol"},{"key":"2022061706384886400_bib38","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.ccr.2005.08.002","article-title":"Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors","volume":"8","author":"De Palma","year":"2005","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib39","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.ccr.2008.01.034","article-title":"HIF1alpha induces the recruitment of bone marrow-derived vascular modulatory cells to regulate tumor angiogenesis and invasion","volume":"13","author":"Du","year":"2008","journal-title":"Cancer Cell"},{"key":"2022061706384886400_bib40","doi-asserted-by":"crossref","first-page":"4174","DOI":"10.1172\/JCI86623","article-title":"Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells","volume":"126","author":"Shenoy","year":"2016","journal-title":"J Clin Invest"},{"key":"2022061706384886400_bib41","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/s41556-018-0138-8","article-title":"Pericyte-like spreading by disseminated cancer cells activates YAP and MRTF for metastatic colonization","volume":"20","author":"Er","year":"2018","journal-title":"Nat Cell Biol"},{"key":"2022061706384886400_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10456-019-09693-x","article-title":"Vascular co-option in brain metastasis","volume":"23","author":"Garc\u00eda-G\u00f3mez","year":"2020","journal-title":"Angiogenesis"},{"key":"2022061706384886400_bib43","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1038\/nature25739","article-title":"A molecular atlas of cell types and zonation in the brain vasculature","volume":"554","author":"Vanlandewijck","year":"2018","journal-title":"Nature"},{"key":"2022061706384886400_bib44","first-page":"1622","article-title":"Cellular plasticity and tumor microenvironment in gliomas: the struggle to hit a moving target","volume-title":"Cancers","author":"Gargini","year":"2020"},{"key":"2022061706384886400_bib45","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s43152-020-00016-7","article-title":"The effect of glioblastoma on pericytes","volume":"1","author":"Molina","year":"2020","journal-title":"Current Tissue Microenvironment Reports"},{"key":"2022061706384886400_bib46","doi-asserted-by":"crossref","first-page":"eaah6816","DOI":"10.1126\/scitranslmed.aah6816","article-title":"Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance","volume":"10","author":"Shi","year":"2018","journal-title":"Sci Transl Med"},{"key":"2022061706384886400_bib47","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/s41588-018-0209-6","article-title":"Pharmacogenomic landscape of patient-derived tumor cells informs precision oncology therapy","volume":"50","author":"Lee","year":"2018","journal-title":"Nat Genet"},{"key":"2022061706384886400_bib48","doi-asserted-by":"crossref","first-page":"dju204","DOI":"10.1093\/jnci\/dju204","article-title":"Selective antitumor activity of ibrutinib in EGFR-mutant non-small cell lung cancer cells","volume":"106","author":"Gao","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"2022061706384886400_bib49","doi-asserted-by":"crossref","first-page":"3484","DOI":"10.1007\/s12032-012-0267-z","article-title":"Oncogenic role of SOX9 expression in human malignant glioma","volume":"29","author":"Wang","year":"2012","journal-title":"Med Oncol"},{"key":"2022061706384886400_bib50","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1517\/14728222.2016.1151002","article-title":"mTOR inhibition decreases SOX2-SOX9 mediated glioma stem cell activity and temozolomide resistance","volume":"20","author":"Garros-Regulez","year":"2016","journal-title":"Expert Opin Ther Targets"},{"key":"2022061706384886400_bib51","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41598-019-57047-w","article-title":"SOX9 promotes tumor progression through the axis BMI1-p21(CIP)","volume":"10","author":"Aldaz","year":"2020","journal-title":"Sci Rep"},{"key":"2022061706384886400_bib52","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1242\/dev.010454","article-title":"Sox9 and Sox10 influence survival and migration of oligodendrocyte precursors in the spinal cord by regulating PDGF receptor alpha expression","volume":"135","author":"Finzsch","year":"2008","journal-title":"Development"},{"key":"2022061706384886400_bib53","doi-asserted-by":"crossref","first-page":"4778","DOI":"10.1074\/jbc.M707729200","article-title":"Hypoxia promotes the differentiated human articular chondrocyte phenotype through SOX9-dependent and -independent pathways","volume":"283","author":"Lafont","year":"2008","journal-title":"J Biol Chem"},{"key":"2022061706384886400_bib54","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1038\/nm.4415","article-title":"Targeting glioma stem cells through combined BMI1 and EZH2 inhibition","volume":"23","author":"Jin","year":"2017","journal-title":"Nat Med"},{"key":"2022061706384886400_bib55","doi-asserted-by":"crossref","first-page":"480","DOI":"10.3389\/fimmu.2016.00480","article-title":"Immune regulation by pericytes: modulating innate and adaptive immunity","volume":"7","author":"Navarro","year":"2016","journal-title":"Front Immunol"},{"key":"2022061706384886400_bib56","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1073\/pnas.1525360113","article-title":"Ang-2\/VEGF bispecific antibody reprograms macrophages and resident microglia to anti-tumor phenotype and prolongs glioblastoma survival","volume":"113","author":"Kloepper","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706384886400_bib57","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1002\/glia.23234","article-title":"VEGF as a modulator of the innate immune response in glioblastoma","volume":"66","author":"Turkowski","year":"2018","journal-title":"Glia"},{"key":"2022061706384886400_bib58","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41467-017-02610-0","article-title":"Angiogenic factor-driven inflammation promotes extravasation of human proangiogenic monocytes to tumours","volume":"9","author":"Sidibe","year":"2018","journal-title":"Nat Commun"},{"key":"2022061706384886400_bib59","doi-asserted-by":"crossref","first-page":"eaak9670","DOI":"10.1126\/scitranslmed.aak9670","article-title":"Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade","volume":"9","author":"Schmittnaegel","year":"2017","journal-title":"Sci Transl Med"},{"key":"2022061706384886400_bib60","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1002\/path.5080","article-title":"Vascular targeting of LIGHT normalizes blood vessels in primary brain cancer and induces intratumoural high endothelial venules","volume":"245","author":"He","year":"2018","journal-title":"JPathol"},{"key":"2022061706384886400_bib61","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11060-012-0988-z","article-title":"Continuous daily sunitinib for recurrent glioblastoma","volume":"111","author":"Kreisl","year":"2013","journal-title":"J Neurooncol"},{"key":"2022061706384886400_bib62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.3816\/CLC.2006.n.002","article-title":"Interactions between hypoxia and epidermal growth factor receptor in non-small-cell lung cancer","volume":"7","author":"Swinson","year":"2006","journal-title":"Clin Lung Cancer"},{"key":"2022061706384886400_bib63","doi-asserted-by":"crossref","first-page":"13092","DOI":"10.1073\/pnas.0702387104","article-title":"Translational up-regulation of the EGFR by tumor hypoxia provides a nonmutational explanation for its overexpression in human cancer","volume":"104","author":"Franovic","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2022061706384886400_bib64","doi-asserted-by":"crossref","first-page":"907","DOI":"10.2174\/138161213804547259","article-title":"The intriguing interplay between therapies targeting the epidermal growth factor receptor, the hypoxic microenvironment and hypoxia-inducible factors","volume":"19","author":"Wouters","year":"2013","journal-title":"Curr Pharm Des"},{"key":"2022061706384886400_bib65","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1038\/s41568-019-0205-x","article-title":"The blood-brain barrier and blood-tumour barrier in brain tumours and metastases","volume":"20","author":"Arvanitis","year":"2020","journal-title":"Nat Rev Cancer"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/8\/2142\/3090524\/2142.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/81\/8\/2142\/3090524\/2142.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T16:36:07Z","timestamp":1655483767000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/81\/8\/2142\/670561\/Tumor-Derived-Pericytes-Driven-by-EGFR-Mutations"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,16]]},"references-count":65,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2021,2,16]]},"published-print":{"date-parts":[[2021,4,15]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-20-3558","relation":{"has-preprint":[{"id-type":"doi","id":"10.1158\/0008-5472.c.6512917","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428133.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428124.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428145","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428118.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428133","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428142.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428151","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428109","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428139","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428136.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428139.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428130.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428112","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428112.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428148.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428142","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428130","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428145.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428118","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.c.6512917.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428148","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428136","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428124","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428151.v1","asserted-by":"object"},{"id-type":"doi","id":"10.1158\/0008-5472.22428109.v1","asserted-by":"object"}]},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,16]]}}}